Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Create Stock SIPAutomate your investments in this
Performance
Open
46.00Prev. Close
42.43Volume
36Total traded value
0.00 CrUpper Circuit
46.67Lower Circuit
38.19Fundamentals
| Market Cap | ₹19Cr |
| ROE | 5.24% |
| P/E Ratio(TTM) | 40.41 |
| EPS(TTM) | 1.05 |
| P/B Ratio | 1.68 |
| Dividend Yield | 0.00% |
| Industry P/E | 40.62 |
| Book Value | 25.22 |
| Debt to Equity | 0.07 |
| Face Value | 10 |
Understand Fundamentals
Financials
About Colinz Laboratories
Colinz Laboratories manufactures and markets pharmaceutical formulations, with a special focus on the gynaecological sector within the Indian domestic market. The company's operations are guided by a philosophy of fair, ethical, and transparent governance, adopting high standards of professionalism and integrity. Highlighting its strong financial management and stability, the company is now a debt-free entity.;
| Parent Organisation | Colinz Laboratories Limited |
| Managing Director | Dr. L. Mani |
| BSE Symbol | 531210 |
Shareholding Pattern
Sep '24
Dec '24
Mar '25
Jun '25
Sep '25
Similar Stocks
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Torrent Pharmaceuticals | NA (0.00%) | 61.33 | ||
| Gland Pharma | NA (0.00%) | 42.19 | ||
| Ajanta Pharma | NA (0.00%) | 32.58 | ||
| Eris Lifesciences | NA (0.00%) | 52.95 |